Personensuche
X
?
2
FDA-approved ALK inhibitors:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s004. , 2024
doi:10.1371/journal.pone.0295966.s004. , 2024
?
3
Supplementary tables:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s001. , 2024
doi:10.1371/journal.pone.0295966.s001. , 2024
?
4
RMSD LigConf values of ATP: Blue, mitoxantrone (MTX): Blue ..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.g007. , 2024
doi:10.1371/journal.pone.0295966.g007. , 2024
?
5
RMSD values of the molecular dynamics:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.g002. , 2024
doi:10.1371/journal.pone.0295966.g002. , 2024
?
6
Heatmap of aminaocid that interact with cdALK + /iALK and c..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s006. , 2024
doi:10.1371/journal.pone.0295966.s006. , 2024
?
7
FDA-approved ALK inhibitors:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s004. , 2024
doi:10.1371/journal.pone.0295966.s004. , 2024
?
8
Pharmacophore 2:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s008. , 2024
doi:10.1371/journal.pone.0295966.s008. , 2024
?
9
Bar graphs of the binding energy in KJoul/mol of each iALK ..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.g001. , 2024
doi:10.1371/journal.pone.0295966.g001. , 2024
?
10
RMSD LigConf values of ATP: Blue, mitoxantrone (MTX): Blue ..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.g007. , 2024
doi:10.1371/journal.pone.0295966.g007. , 2024
?
11
Fold change of binding energy between drugs and cdALK +:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.g004. , 2024
doi:10.1371/journal.pone.0295966.g004. , 2024
?
12
Supplementary tables:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s001. , 2024
doi:10.1371/journal.pone.0295966.s001. , 2024
?
13
Heatmap of aminaocid that interact with cdALK + /iALK and c..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s006. , 2024
doi:10.1371/journal.pone.0295966.s006. , 2024
?
14
S3 Fig -:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.s005. , 2024
doi:10.1371/journal.pone.0295966.s005. , 2024
?
15
Receptor-ligand based pharmacophore models and their distin..:
Juan Enrique Faya Castillo ; Richard Junior Zapata Dongo ; Paolo Alberto Wong Chero.
doi:10.1371/journal.pone.0295966.t001. , 2024
doi:10.1371/journal.pone.0295966.t001. , 2024